THERESA O' HAIR: Open Payments
NPI 1942467519 · OROVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 41 payments from 17 companies in 2025. Trend: 2023 $540 · 2024 $985 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 7 | $175 |
| PFIZER INC. | 6 | $149 |
| Merck Sharp & Dohme LLC | 4 | $117 |
| Gilead Sciences, Inc. | 2 | $106 |
| Novo Nordisk Inc | 3 | $91 |
| Lilly USA, LLC | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Indivior Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $41 |
Products named: APRETUDE, PIFELTRO, NURTEC ODT, Yeztugo, Ozempic, DOVATO, Kerendia, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
